Posted inEuronext
argenx to acquire Forte Biosciences for $2.2 billion
AMSTERDAM: argenx (Euronext & Nasdaq: ARGX), a global immunology innovation company, announced today that it has entered into a definitive agreement to acquire Forte Biosciences, Inc. (Nasdaq: FBRX) for $77 per share…











